NCT03957382
Active, not recruiting
Not Applicable
Evaluation of Safety and Efficacy of the Accero® (Heal) Stent for Intracranial Aneurysm Treatment
ConditionsIntracranial Aneurysm
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Intracranial Aneurysm
- Sponsor
- Acandis GmbH
- Enrollment
- 130
- Locations
- 4
- Primary Endpoint
- Raymond Roy Classification
- Status
- Active, not recruiting
- Last Updated
- 5 months ago
Overview
Brief Summary
This study is intended to show that the application of the Accero® (heal) stent is safe within the given indication.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Any patient treated with ACCERO® (heal) Stent according to IFU and has signed the informed consent
Exclusion Criteria
- •\- Patient is participating in another clinical trial
Outcomes
Primary Outcomes
Raymond Roy Classification
Time Frame: 36 months after treatment
Assessment of Raymond Roy Classification
Secondary Outcomes
- modified Rankin Scale (mRS)(36 months after treatment)
Study Sites (4)
Loading locations...
Similar Trials
Completed
Phase 3
Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)Coronary DiseaseNCT00165035Cordis Corporation1,701
Recruiting
Not Applicable
REscue Stenting With CREDO® Heal for Recanalisation After Unsuccessful Thrombectomy (RECHRUT)Rescue StentingNCT05345483Acandis GmbH153
Completed
Phase 2
Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) ElevationEye DiseasesNCT00315640Alcon Research70
Completed
Not Applicable
Evaluation of Effectiveness and Safety of the GENOUS STENT (IRIS-GENOUS STEMI)Coronary Artery DiseaseNCT01348373Seung-Jung Park464
Unknown
Not Applicable
Efficacy and Safety Evaluation of HCPA-1 Silicone Stent in the Treatment of Central Airway ObstructionsTracheobronchomalaciaNCT01389531Hospital de Clinicas de Porto Alegre110